Jim Simons’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $278K | Buy |
99,590
+18,490
| +23% | +$62.8K | ﹤0.01% | 2816 |
|
|
2025
Q4 | $297K | Buy |
81,100
+40,300
| +99% | +$115K | ﹤0.01% | 2767 |
|
|
2025
Q3 | $151K | Buy |
+40,800
| New | +$103K | ﹤0.01% | 3193 |
|
|
2025
Q2 | – | Sell |
-32,000
| Closed | -$49.9K | – | 3646 |
|
|
2025
Q1 | $49.9K | Sell |
32,000
-143,800
| -82% | -$253K | ﹤0.01% | 3290 |
|
|
2024
Q4 | $356K | Buy |
175,800
+97,712
| +125% | +$177K | ﹤0.01% | 2985 |
|
|
2024
Q3 | $113K | Buy |
+78,088
| New | +$149K | ﹤0.01% | 3241 |
|
|
2024
Q1 | – | Sell |
-25,867
| Closed | -$78K | – | 3807 |
|
|
2023
Q4 | $78K | Buy |
25,867
+4,292
| +20% | +$11.3K | ﹤0.01% | 3366 |
|
|
2023
Q3 | $94K | Buy |
21,575
+6,347
| +42% | +$43.5K | ﹤0.01% | 3262 |
|
|
2023
Q2 | $126K | Sell |
15,228
-1,605
| -10% | -$15.9K | ﹤0.01% | 3418 |
|
|
2023
Q1 | $207K | Buy |
16,833
+613
| +4% | +$7.3K | ﹤0.01% | 3262 |
|
|
2022
Q4 | $159K | Sell |
16,220
-13,153
| -45% | -$146K | ﹤0.01% | 3492 |
|
|
2022
Q3 | $379K | Sell |
29,373
-8,300
| -22% | -$124K | ﹤0.01% | 3082 |
|
|
2022
Q2 | $475K | Sell |
37,673
-35,747
| -49% | -$530K | ﹤0.01% | 3191 |
|
|
2022
Q1 | $1.5M | Buy |
73,420
+66,777
| +1,005% | +$1.83M | ﹤0.01% | 2440 |
|
|
2021
Q4 | $249K | Buy |
+6,643
| New | +$296K | ﹤0.01% | 3421 |
|
|
2020
Q4 | – | Sell |
-1,987
| Closed | -$120K | – | 3482 |
|
|
2020
Q3 | $120K | Sell |
1,987
-38,280
| -95% | -$1.95M | ﹤0.01% | 3186 |
|
|
2020
Q2 | $1.62M | Buy |
40,267
+6,967
| +21% | +$259K | ﹤0.01% | 2293 |
|
|
2020
Q1 | $944K | Buy |
33,300
+8,760
| +36% | +$291K | ﹤0.01% | 2454 |
|
|
2019
Q4 | $946K | Buy |
24,540
+12,765
| +108% | +$328K | ﹤0.01% | 2658 |
|
|
2019
Q3 | $249K | Buy |
11,775
+10,673
| +969% | +$251K | ﹤0.01% | 3086 |
|
|
2019
Q2 | $25K | Buy |
+1,102
| New | +$28.3K | ﹤0.01% | 3489 |
|
|
2019
Q1 | – | Sell |
-10,850
| Closed | -$140K | – | 3513 |
|
|
2018
Q4 | $140K | Sell |
10,850
-14,365
| -57% | -$240K | ﹤0.01% | 3191 |
|
|
2018
Q3 | $605K | Buy |
25,215
+17,395
| +222% | +$557K | ﹤0.01% | 2788 |
|
|
2018
Q2 | $350K | Buy |
7,820
+1,480
| +23% | +$83.3K | ﹤0.01% | 2928 |
|
|
2018
Q1 | $433K | Buy |
6,340
+3,013
| +91% | +$191K | ﹤0.01% | 2963 |
|
|
2017
Q4 | $199K | Sell |
3,327
-4,346
| -57% | -$256K | ﹤0.01% | 3137 |
|
|
2017
Q3 | $509K | Buy |
7,673
+4,826
| +170% | +$325K | ﹤0.01% | 2781 |
|
|
2017
Q2 | $203K | Buy |
+2,847
| New | +$168K | ﹤0.01% | 2995 |
|
|
2014
Q4 | – | Sell |
-12,515
| Closed | -$394K | – | 3010 |
|
|
2014
Q3 | $394K | Sell |
12,515
-22,412
| -64% | -$595K | ﹤0.01% | 2388 |
|
|
2014
Q2 | $901K | Buy |
34,927
+8,766
| +34% | +$231K | ﹤0.01% | 2096 |
|
|
2014
Q1 | $777K | Buy |
26,161
+23,823
| +1,019% | +$929K | ﹤0.01% | 2184 |
|
|
2013
Q4 | $92K | Buy |
+2,338
| New | +$90.3K | ﹤0.01% | 2737 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Jim Simons's FBIO Position: Q1 2026 in Review
Jim Simons increased its Fortress Biotech (FBIO) stake by 23% in Q1 2026, buying an estimated $62.8K and bringing the position to 99,590 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #2816.
Jim Simons first reported a position in FBIO in Q4 2013 and has held it in 32 quarters since. The position peaked at $1.62M in Q2 2020. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Jim Simons held 99,590 shares of Fortress Biotech worth $278K as of Q1 2026.
- Jim Simons bought 18,490 Fortress Biotech shares in Q1 2026, an estimated $62.8K.
- Fortress Biotech made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2816 holding.
- Jim Simons first reported a position in Fortress Biotech in Q4 2013 and has held it in 32 quarters since.
- Jim Simons's Fortress Biotech position peaked at $1.62M in Q2 2020.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.